Considering all patients, or restricting the analysis to severe SCD subtypes only, we found no evidence of any effect of Glucose-6-Phosphate dehydrogenase (G6PD) deficiency or α-thalassemia (deletion of one or two α genes) on IgG, IgA, and IgM levels over time. The gene discussed is CD79A; the disease is G6PD deficiency.